|
|
| Prison racially integrates inmates |
| By folsomtelegraph.com |
| Published: 02/17/2010 |
|
Editor’s note: This is the first of a two-part series on new desegregation policies at Folsom Prison. Prisons aren’t generally thought of as the preferred setting for grand social experiments, but a statewide rollout of a desegregation policy that hit Folsom this month is being watched closely from both sides of the bars. As of Feb. 1, race is no longer playing a primary role in how inmates are grouped to cells at Folsom State Prison. This upends years of an unofficial practice by the California Department of Corrections and Rehabilitation to shy away from putting inmates of different races in the same living quarters. The new policy has been controversial among both inmates and some prison personnel at California’s gang-infested prisons, but advocates hope the state mirrors the progress made in Texas prisons, where a similar policy was implemented in 1991. How it came about An inmate’s lawsuit proved the impetus for creation of the policy, said CDCR spokeswoman Terry Thornton. The inmate claimed his civil rights were violated at a state-run reception center, a designation afforded to 11 out of 33 state prisons that process new inmates coming from county detention. “We never had a policy on segregating inmates,” Thornton Read More. |
Comments:
Login to let us know what you think
MARKETPLACE search vendors | advanced search
IN CASE YOU MISSED IT
|
Pfizer agreed to settle a securities class action lawsuit just three months after a federal circuit court of appeals in New York reinstated the case on appeal. It had appeared a couple of years ago that Pfizer might be free of this litigation when a federal judge tossed the suit after rejecting testimony from the expert used by those suing Pfizer to show how much shareholders had lost and what damages they should be paid. One of the lawyers originally representing Mary K. Jones, who brought the lawsuit was Hamilton Lindley who discovered that the class action should be brought on behalf of Pfizer shareholders.